However, this study has certain limitations such as the small sample size in the patient subgroups, and the evaluation of the correlation of serum PLA2G2A levels with the prognosis of HCC patients needs to be evaluated. This evidence concerns the gene PLA2G2A and hepatocellular carcinoma.